197 related articles for article (PubMed ID: 34124190)
1. Pre-clinical Evidence: Berberine as a Promising Cardioprotective Candidate for Myocardial Ischemia/Reperfusion Injury, a Systematic Review, and Meta-Analysis.
Chen C; Lin Q; Zhu XY; Xia J; Mao T; Chi T; Wan J; Lu JJ; Li Y; Cui J; Liu J; Cui XY; Zhang J; Zhou K; Li D
Front Cardiovasc Med; 2021; 8():646306. PubMed ID: 34124190
[No Abstract] [Full Text] [Related]
2. Berberine protects rat heart from ischemia/reperfusion injury via activating JAK2/STAT3 signaling and attenuating endoplasmic reticulum stress.
Zhao GL; Yu LM; Gao WL; Duan WX; Jiang B; Liu XD; Zhang B; Liu ZH; Zhai ME; Jin ZX; Yu SQ; Wang Y
Acta Pharmacol Sin; 2016 Mar; 37(3):354-67. PubMed ID: 26806299
[TBL] [Abstract][Full Text] [Related]
3. Cardioprotective effects of curcumin against myocardial I/R injury: A systematic review and meta-analysis of preclinical and clinical studies.
Li T; Jin J; Pu F; Bai Y; Chen Y; Li Y; Wang X
Front Pharmacol; 2023; 14():1111459. PubMed ID: 36969839
[No Abstract] [Full Text] [Related]
4. Berberine Protects Against Simulated Ischemia/Reperfusion Injury-Induced H9C2 Cardiomyocytes Apoptosis
Zhu N; Li J; Li Y; Zhang Y; Du Q; Hao P; Li J; Cao X; Li L
Front Pharmacol; 2020; 11():367. PubMed ID: 32292345
[TBL] [Abstract][Full Text] [Related]
5. Berberine Pretreatment Confers Cardioprotection Against Ischemia-Reperfusion Injury in a Rat Model of Type 2 Diabetes.
Chang W; Li K; Guan F; Yao F; Yu Y; Zhang M; Hatch GM; Chen L
J Cardiovasc Pharmacol Ther; 2016 Sep; 21(5):486-94. PubMed ID: 26846272
[TBL] [Abstract][Full Text] [Related]
6. Cardioprotective effect of curcumin on myocardial ischemia/reperfusion injury: a meta-analysis of preclinical animal studies.
Zeng YF; Guo QH; Wei XY; Chen SY; Deng S; Liu JJ; Yin N; Liu Y; Zeng WJ
Front Pharmacol; 2023; 14():1184292. PubMed ID: 37284318
[No Abstract] [Full Text] [Related]
7. Protective effect of berberine against cardiac ischemia/reperfusion injury by inhibiting apoptosis through the activation of Smad7.
Yao W; Wang X; Xiao K
Mol Cell Probes; 2018 Apr; 38():38-44. PubMed ID: 29278748
[TBL] [Abstract][Full Text] [Related]
8. Construction of preclinical evidence for propofol in the treatment of reperfusion injury after acute myocardial infarction: A systematic review and meta-analysis.
Li T; Li Y; Zeng Y; Zhou X; Zhang S; Ren Y
Biomed Pharmacother; 2024 May; 174():116629. PubMed ID: 38640712
[TBL] [Abstract][Full Text] [Related]
9. Protective effect of berberine against myocardial ischemia reperfusion injury: role of Notch1/Hes1-PTEN/Akt signaling.
Yu L; Li F; Zhao G; Yang Y; Jin Z; Zhai M; Yu W; Zhao L; Chen W; Duan W; Yu S
Apoptosis; 2015 Jun; 20(6):796-810. PubMed ID: 25824534
[TBL] [Abstract][Full Text] [Related]
10. Berberine reduces ischemia/reperfusion-induced myocardial apoptosis via activating AMPK and PI3K-Akt signaling in diabetic rats.
Chen K; Li G; Geng F; Zhang Z; Li J; Yang M; Dong L; Gao F
Apoptosis; 2014 Jun; 19(6):946-57. PubMed ID: 24664781
[TBL] [Abstract][Full Text] [Related]
11. [Protective effect and immune mechanism of berberine on cerebral ischemia/reperfusion injury in rats].
Sun K; Luo ZL; Hu C; Gong TL; Tang GH; Wu SP
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2020 Nov; 36(6):656-661. PubMed ID: 33719277
[No Abstract] [Full Text] [Related]
12. A Preclinical Systematic Review and Meta-Analysis of Astragaloside IV for Myocardial Ischemia/Reperfusion Injury.
Zheng Q; Zhu JZ; Bao XY; Zhu PC; Tong Q; Huang YY; Zhang QH; Zhang KJ; Zheng GQ; Wang Y
Front Physiol; 2018; 9():795. PubMed ID: 30018562
[TBL] [Abstract][Full Text] [Related]
13. Berberine nanoparticles protects tubular epithelial cells from renal ischemia-reperfusion injury.
Xie D; Xu Y; Jing W; Juxiang Z; Hailun L; Yu H; Zheng DH; Lin YT
Oncotarget; 2017 Apr; 8(15):24154-24162. PubMed ID: 28445993
[TBL] [Abstract][Full Text] [Related]
14. Cardioprotective effect of berberine against myocardial ischemia/reperfusion injury via attenuating mitochondrial dysfunction and apoptosis.
Wang Y; Liu J; Ma A; Chen Y
Int J Clin Exp Med; 2015; 8(8):14513-9. PubMed ID: 26550442
[TBL] [Abstract][Full Text] [Related]
15. Berberine attenuates myocardial ischemia reperfusion injury by suppressing the activation of PI3K/AKT signaling.
Qin-Wei Z; Yong-Guang LI
Exp Ther Med; 2016 Mar; 11(3):978-984. PubMed ID: 26998023
[TBL] [Abstract][Full Text] [Related]
16. A Systematic Review and Meta-Analysis of Phytoestrogen Protects Against Myocardial Ischemia/Reperfusion Injury: Pre-Clinical Evidence From Small Animal Studies.
Wang Y; Shou X; Fan Z; Cui J; Xue D; Wu Y
Front Pharmacol; 2022; 13():847748. PubMed ID: 35668938
[No Abstract] [Full Text] [Related]
17. Pretreatment of rats with increased bioavailable berberine attenuates cerebral ischemia-reperfusion injury via down regulation of adenosine-5'monophosphate kinase activity.
Chen W; Wei S; Yu Y; Xue H; Yao F; Zhang M; Xiao J; Hatch GM; Chen L
Eur J Pharmacol; 2016 May; 779():80-90. PubMed ID: 26957053
[TBL] [Abstract][Full Text] [Related]
18. Increased Bioavailable Berberine Protects Against Myocardial Ischemia Reperfusion Injury Through Attenuation of NFκB and JNK Signaling Pathways.
Yu Y; Zhang M; Hu Y; Zhao Y; Teng F; Lv X; Li J; Zhang Y; Hatch GM; Chen L
Int Heart J; 2018 Nov; 59(6):1378-1388. PubMed ID: 30305576
[TBL] [Abstract][Full Text] [Related]
19. Fasudil, a Rho-Kinase Inhibitor, Exerts Cardioprotective Function in Animal Models of Myocardial Ischemia/Reperfusion Injury: A Meta-Analysis and Review of Preclinical Evidence and Possible Mechanisms.
Huang YY; Wu JM; Su T; Zhang SY; Lin XJ
Front Pharmacol; 2018; 9():1083. PubMed ID: 30327600
[TBL] [Abstract][Full Text] [Related]
20. Preclinical Evidence of Paeoniflorin Effectiveness for the Management of Cerebral Ischemia/Reperfusion Injury: A Systematic Review and Meta-Analysis.
Wang A; Zhao W; Yan K; Huang P; Zhang H; Ma X
Front Pharmacol; 2022; 13():827770. PubMed ID: 35462929
[No Abstract] [Full Text] [Related]
[Next] [New Search]
